The 69th Annual Meeting of the Japanese Society for Virology

Presentation information

Oral

[O2-5] Hepadnavirus2

Mon. Nov 14, 2022 1:50 PM - 3:20 PM Room 5 (Conference Room 109)

Chair:Tomoyuki Honda(Department of Virology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University), Ryosuke Suzuki(National Institute of Infectious Diseases)

2:35 PM - 2:50 PM

[O2-5-4] A novel bile acid derivative inhibits HBV infection via sodium taurocholate co-transporting polypeptide

*GN Rsi Suwardana1, Takayuki Abe1, Kuroki Daisuke1, Lin Deng1, Chieko Matsui1, Masafumi Ueda2, Takahashi Okitsu3, Manabu Hatano3, Kunitada Shimotohno4, Ikuo Shoji1 (1. Division of Infectious Disease Control, Center for Infectious Diseases, Kobe University Graduate School of Medicine, Kobe, Japan, 2. Medicinal Chemistry Laboratory, Kobe Pharmaceutical University, Kobe, Japan, 3. Laboratory of Organic Chemistry for Life Science, Kobe Pharmaceutical University, Kobe, Japan, 4. National Center for Global Health and Medicine, Chiba, Japan)

Abstract password authentication.
You need a password to access the abstructs of JSV67.
The password is on
your certificate of Participation.

Password